SCHEMBL25980818

SCHEMBL25980818

CCc1cc(N(Cc2ccc(C(=O)NOI)cc2)C(=O)N2CCN(CC)CC2)ccc1C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
KCNH2 Q12809 1/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 6/20 0.35
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
ALOX12 P18054 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TP53 P04637 2/20 0.34
CCR5 P51681 1/20 0.34
HDAC1 Q13547 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM1 P11229 1/20 0.33
MCHR1 Q99705 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25980814 0.93 ALDH1A1 (0.40) SMN1; SMN2KCNH2LMNAKMT2AALDH1A1
SCHEMBL25980762 0.91 HDAC1 (0.39) SMN1; SMN2KCNH2LMNAHPGDKMT2A
SCHEMBL25980785 0.90 HDAC1 (0.40) SMN1; SMN2HPGDKMT2AALDH1A1MAPT
SCHEMBL25980773 0.89 MERTK (0.40) SMN1; SMN2KCNH2LMNAHPGDKMT2A
SCHEMBL25980807 0.85 L3MBTL1 (0.38) SMN1; SMN2KCNH2HPGDKMT2AALDH1A1
SCHEMBL25981206 0.82 CCR5 (0.41) SMN1; SMN2KCNH2HPGDKMT2AALDH1A1
SCHEMBL25981775 0.79 HPGD (0.47) SMN1; SMN2HPGDKMT2AALDH1A1TP53
SCHEMBL20236524 0.77 HRH3 (0.43) KCNH2HPGDKMT2A
SCHEMBL25979342 0.77 POLB (0.44) SMN1; SMN2HPGDKMT2AALDH1A1MAPT
SCHEMBL22218241 0.76 HPGD (0.42) SMN1; SMN2LMNAHPGDKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) NR1H2, CFTR, CYP11B2 SMN1; SMN2 4332/4885KCNH2 3526/4885LMNA 2240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.